Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients.

Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 6

Abstract

In order to elucidate the mechanism of intravenous methylprednisolone (IVMP) therapy of relapses in multiple sclerosis (MS) patients, we have undertaken a study on the expression of the chemokines: soluble platelet endothelial cell adhesion molecule (sPECAM-1) and interferon gamma-inducible protein (CXCL10), before and after treatment. As more becomes known about the mechanism of methylprednisolone (MP) action, it may be possible to find a more specific treatment as well for the individual patients as the phase of the disease. The mean level of sPECAM-1 in our material was almost identical in either the MS and control subjects. After a 5-day therapy with IVMP, no changes were found in comparison with the starting value. The serum concentration of CXCL10 in MS patients was found to be higher compared to that in sera from control subjects. After therapy with IVMP the mean level of CXCL10 was diminished to the initial value and occasionally was even lower than in the control group. The findings established in our present study indicate that IVMP diminished significantly the elevated expression of CXCL10, which seems to be an important factor in the mechanism of this drug action on MSrelapses. It is important to stress that the reaction is not a general one because there was no effect on the expression of sPECAM-1.

Authors and Affiliations

Grażyna Michałowska-Wender, Jacek Losy, Adam Szczuciński, Justyna Biernacka-Łukanty, Mieczysław Wender

Keywords

Related Articles

Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels.

The aim of the present study was to investigate the role of GABAergic and nitriergic modulation in the antianxiety effect of thymoquinone, a major constituent of Nigella sativa, in mice under unstressed and stressed cond...

Effects of some new antidepressant drugs on the glucocorticoid receptor-mediated gene transcription in fibroblast cells.

Antidepressant drugs are thought to counteract effects of hypercortisolemia, frequently associated with depression, by lowering cortisol level and by modifying the function of glucocorticoid receptors (GR). Indeed, class...

Effect of N-benzoyl-D-phenylalanine, a new potential oral antidiabetic agent, in neonatal streptozotocin-induced diabetes in rats.

The present investigation was undertaken to study the effect of treatment with D-phenylalanine derivative and metformin in neonatal streptozotocin (nSTZ)-induced non-insulin-dependent diabetes mellitus (NIDDM) in rats. T...

Prodrugs: A challenge for the drug development.

It is estimated that about 10% of the drugs approved worldwide can be classified as prodrugs. Prodrugs, which have no or poor biological activity, are chemically modified versions of a pharmacologically active agent, whi...

Download PDF file
  • EP ID EP159855
  • DOI -
  • Views 95
  • Downloads 0

How To Cite

Grażyna Michałowska-Wender, Jacek Losy, Adam Szczuciński, Justyna Biernacka-Łukanty, Mieczysław Wender (2006). Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients.. Pharmacological Reports, 58(6), 920-923. https://europub.co.uk/articles/-A-159855